CHRIS DRIVER

Chris Driver is currently Director, IT Architecture at IQVIA, with over 20 years of experience in the IRT and Biotechnology space, and across a number of R&D and Information Technology functions. Chris’s experience and background in infrastructure architecture, global health platforms and more recently, decentralized trial adoption through real-time integrations, drives his enthusiasm for the future state of patient-centered health care. In his “downtime”, Chris enjoys spending time with his growing family, advocating for adoption, especially for those blessed with an extra chromosome!

BRITTNEY ELKO

Brittney is Director, Head of Supply Chain at Tricida where she is responsible for the clinical supply group managing investigational drug and ancillary supplies for Tricida’s global 1600 patient confirmatory post marketing trial for TRC 101 as well as the commercial supply chain group preparing for the launch of TRC 101 / Veverimer in the later part of 2020. Brittney has more than 12 years of experience working in both technical development and supply chain organizations. Prior to Tricida, she was at Intarcia and Genentech where she managed all aspects of supplying clinical trials. From developing forecasts from protocols, translating these forecasts to manufacturing plans and appropriate inventory levels, assessing the supply status of clinical sites and putting in place delivery plans that take into account production, release and distribution timing to ensure no stock-out situations at clinics, Brittney has extensive experience in forecasting creation and hopes to share those tools with you today. She also managed the commercial supply chain for the Clorox Disinfecting Wipes business, dealing with un-precedented demand changes through the H1N1 flu outbreak.

CRAIG MOONEY

Craig joined Calyx in 2021 as Vice President Scientific eTech Enabled Services, Craig has nearly 30 years of experience in the clinical trial arena including clinical operations, IMP packaging, labeling & logistics, with a primary focus in Interactive Response Technology (IRT). In his current role Craig’s remit is to: Leverage experience as an IRT business owner & sponsor to drive excellence in product, project management, and commercialization; Consult with clients on IRT best practices and emerging trends in the regulatory landscape; Serve as an advocate for sponsors within Calyx through expanded partnership engagements; And contribute to the industry as an evangelist for IRT and its proper role in clinical trials.

MARC LISI

Marc has spent his entire career in the eClinical technologies space, with most of that time focused in the area of IRT. Having spent years on the client services side, Marc has worked with 7 of the top 10 pharmaceutical companies and 6 of the top 7 CROs to design, implement, and maintain IRT solutions across a variety of therapeutic areas. As a Co-founder and Director of Business Development at Suvoda, Marc uses his IRT subject matter expertise to provide creative solutions to customers’ problems, all while growing Suvoda’s business globally. Marc enjoys creating long-lasting relationships with customers and colleagues and loves brokering introductions within his network. Marc is a graduate of Lafayette College with a degree in biochemistry and minor in music.

ISAAC BLUM

Isaac Blum is currently the Senior Manager of Clinical Supply at ALX Oncology in South San Francisco, California. Previously, Isaac oversaw clinical supply chain operations at Puma Biotechnology and Sangamo Therapeutics. Isaac is excited about optimizing drug supply operations to help advance innovative, life-saving treatments. He has used his expertise to launch multiple global oncology clinical trials, and enjoys collaborating with others in the field through speaking at conferences and workshops. In his free time, Isaac enjoys hiking, running and spending time with his family.

PHIL CHOU

Phil is a supply chain professional working exclusively in the clinical space for over 15 years. He has managed all aspects of clinical supply, packaging and labeling and distribution, IXRS setup and management. He has worked with the following companies: Rainier Therapeutics Aimmune Therapeutics Myovant Sciences Onyx Pharmaceuticals Elan Pharmaceuticals